Chronic Periodontitis Clinical Trial
Official title:
Evaluation of Possible Genes in Periodontal Diseases by Genetic Methods
Generalized aggressive Periodontitis (GAgP) and chronic periodontitis (CP) are inflammatory
diseases. Little is known about molecular changes and signaling cascade of host response.
Inflammatory diseases are undercontrol of genetic and enviromental factors. Transcription
factors are gene-specific factors that are often considered to act as a link connecting
genetic and enviromental factors.
The aim of this study is to investigate the gene regions that are thought to play a role in
the pathogenesis of GAgP and CP, and to interpret new and reliable pathognomonic-prognostic
markers in the diagnosis and treatment of these diseases with the help of expression and
mutation analyzes and polymorphism studies.
Generalized aggressive Periodontitis (GAgP) is a multifactorial, destructive, inflammatory
and complex disease. The progression of the disease is undercontrol of immunologic,
microbiologic, environmental and genetic factors. The immunologic and genetic factors are not
clearly defined yet.
Chronic periodontitis (CP) is an infectious disease resulting within the supporting tissues
of the teeth. It is commonly detected in adults. CP is initiated and sustained by bacterial
plaque.
Both AgP and CP are inflammatory diseases. Little is known about molecular changes and
signaling cascade of host response. Inflammatory diseases are undercontrol of genetic and
environmental factors. Transcription factors are gene-specific factors that are often
considered to act as a link connecting genetic and environmental factors.
This research is a continuation project. In the previous 2 studies which were conducted and
published with the support of TÜBİTAK 1001 and KOU BAP, it was found 2 gene regions thought
to have an effect on GAgP and KP pathogenesis by genomics, proteomics and immunohistochemical
methods; MZB1 and ECH1. The aim of this study is to confirm these gene regions by gene
expression analysis, mutation analysis and polymorphism studies.
In the literature, there was no study on the genome analysis, protein activity and
immunohistochemical examination of these genes in the CP and GAgP. There was no study that
evaluated the expression, mutation and polymorphism studies.
The first 2 steps of the study were completed with the support provided by Kocaeli University
Scientific Research Project Unit [119.500,00 TL (KOU BAP 2013/5)] and TUBITAK [(TÜBİTAK 1001
214S008, 261.500,00 TL)].
The aim of this study is to investigate the gene regions that are thought to play a role in
the pathogenesis of GAgP and CP, and to interpret new and reliable pathognomonic-prognostic
markers in the diagnosis and treatment of these diseases with the help of expression and
mutation analyzes and polymorphism studies. Gene sites identified and clinically relevant in
this study will serve as the basis for another study in which these genes are aimed at
silencing.,,,
This research is a continuation project. In the previous 2 studies which were conducted and
published with the support of TÜBİTAK 1001 and KOU BAP, it was found 2 gene regions that
concluded which may have an effect on GAgP and KP pathogenesis by genomics, proteomics and
immunohistochemical methods; MZB1 and ECH1. The aim of this study is to confirm these gene
regions by gene expression analysis, mutation analysis and polymorphism studies.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06400069 -
Role of NLRP6 in Chronic Periodontitis
|
||
Completed |
NCT05231096 -
Comparison of the Effect of Gingival Massage of Aloe-vera Gel and Sidr Honey on Chronic Periodontitis
|
N/A | |
Completed |
NCT03203746 -
Gingival Crevicular Fluid Levels of Protein Carbonyl Following the Use of Lycopene in Chronic Periodontitis
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03354338 -
Amoxicillin to Prevent Bacteria and Inflammatory Biomarkers After Intensive Periodontal Therapy
|
Phase 2 | |
Completed |
NCT02516111 -
Comparison of Autologous PRF, 1% Alendronate and 1.2% Atorvastatin Gel in Chronic Periodontitis Treatment
|
Phase 2/Phase 3 | |
Completed |
NCT02174146 -
Leptin and Visfatin in Diabetic Patients With Periodontitis Before and After Periodontal Therapy
|
N/A | |
Terminated |
NCT02568163 -
Influence of Stress on Non Surgical Periodontal Treatment
|
N/A | |
Completed |
NCT02430519 -
Benefits of Platelet Rich Fibrin In Mandibular Molar Furcation Defects
|
N/A | |
Completed |
NCT01233765 -
Analysis of Neutrophil Response in Chronic Periodontitis
|
N/A | |
Completed |
NCT01438333 -
Efficacy of INERSAN in Patients With Chronic Periodontitis as Adjunctive to Full Mouth Disinfection
|
N/A | |
Completed |
NCT02218515 -
Treatment of Intrabony Periodontal Defects With Enamel Matrix Derivatives and Autogenous Bone Graft
|
Phase 4 | |
Completed |
NCT02197260 -
Antimicrobial Therapy as Adjunct to Periodontal Treatment: Effect of Timing
|
Phase 4 | |
Not yet recruiting |
NCT03270280 -
Comparison of Salivary Interleukin-1β and Matrix Metalloproteinase-8 Levels in Individuals With Chronic Periodontitis
|
Phase 2 | |
Completed |
NCT04697199 -
The Adjunctive Effect of Probiotics to Non Surgical Treatment of Chronic Periodontitis
|
Phase 1 | |
Completed |
NCT04643288 -
Nanocrystalline Hydroxyapatite Bone Substitute for Treating Periodontal Intrabony Defects
|
N/A | |
Completed |
NCT03039244 -
Evaluation of Antimicrobial Photodynamic Therapy as an Adjunct to Periodontal Treatment in Smokers
|
N/A | |
Completed |
NCT02518152 -
Platelet Rich Fibrin+1% Alendronate in Treatment of Chronic Periodontitis
|
Phase 2/Phase 3 | |
Completed |
NCT02851823 -
Combined Use of Er:YAG and Nd:YAG Laser
|
N/A | |
Completed |
NCT03874390 -
Effects of Ozone Therapy on Clinical Parameters and Inflammatory Cytokines in Chronic Periodontitis Patients
|
N/A | |
Completed |
NCT02898675 -
Advantages of Autologous Platelet-Rich Fibrin Membrane on Growth Factor Levels and Periodontal Healing
|
N/A |